CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 8-K Event Executive or director change
- 8-K/A Event Exhibits
- 8-K Event Executive or director change
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 423 shares at an average $4.56 ($1,930)
- 4 Open-market buy Director bought 394 shares at an average $4.54 ($1,790)
- 4 Open-market buy Chairman and CEO bought 394 shares at an average $4.54 ($1,790)
- 4 Open-market buy Director bought 1,956 shares at an average $4.51 ($8,817)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,114 shares at an average $4.53 ($9,571)
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Open-market buy Chief Financial Officer bought 3,800 shares at $2.35 ($8,930)
- 4 Open-market buy Director bought 284 shares at an average $2.65 ($753)
- 4 Open-market buy Director bought 882 shares at an average $2.72 ($2,402)
Page 16 of 52 · 1,039 filings